Harapan Biyan Nathanael, Forbrig Robert, Liebig Thomas, Schichor Christian, Thorsteinsdottir Jun
Department of Neurosurgery, LMU University Hospital, LMU Munich, 81377 Munich, Germany.
Institute of Neuroradiology, LMU University Hospital, LMU Munich,81377 Munich, Germany.
J Clin Med. 2025 Mar 31;14(7):2398. doi: 10.3390/jcm14072398.
: Spinal subarachnoid hemorrhage (sSAH) is a very rare disease. Detailed information about the natural course, pathogenesis, radiological manifestation, and therapeutic management is lacking. This study aimed to analyze patients diagnosed with sSAH, focusing on the origin, management strategies, and therapeutic approaches to sSAH. : The study included a cohort of patients admitted to the Department of Neurosurgery, LMU University Hospital, LMU Munich, between January 2021 and December 2024 with a confirmed diagnosis of spinal subarachnoid hemorrhage and, among other things, spinal aneurysms. Data on the included patients were recorded with emphasis on demographics, radiological examination (CT, MRI, and DSA), aneurysm-specific characteristics, and clinical outcome. : The study included six patients diagnosed with spinal subarachnoid hemorrhage via multimodal imaging. The etiology of sSAH was identified in all cases, encompassing spinal aneurysms in three patients, anticoagulation therapy in two cases, and bony microspurs in one case, with management strategies tailored as either conservative (monitoring and imaging) or surgical (aneurysm resection, arterial feeder coagulation, or evacuation of intraspinal bleeding). No major adverse events were observed, and all the patients demonstrated neurological improvement or exhibited only mild-to-moderate disability during follow-up. : Spinal subarachnoid hemorrhage can be due to a ruptured spinal aneurysm, but in some cases, other underlying causes should be considered as the source of the hemorrhage. Given the scarcity of literature on this condition, it is crucial to identify the correct diagnosis and implement a patient-tailored therapeutic approach.
脊髓蛛网膜下腔出血(sSAH)是一种非常罕见的疾病。目前缺乏关于其自然病程、发病机制、影像学表现和治疗管理的详细信息。本研究旨在分析诊断为sSAH的患者,重点关注sSAH的起源、管理策略和治疗方法。
该研究纳入了2021年1月至2024年12月期间在慕尼黑大学医院神经外科住院的一组患者,这些患者经确诊患有脊髓蛛网膜下腔出血,其中部分患者还患有脊髓动脉瘤。记录了纳入患者的数据,重点包括人口统计学信息、影像学检查(CT、MRI和DSA)、动脉瘤的具体特征以及临床结果。
该研究纳入了6例经多模态影像学诊断为脊髓蛛网膜下腔出血的患者。所有病例均明确了sSAH的病因,包括3例脊髓动脉瘤、2例抗凝治疗相关病例以及1例骨微刺导致的病例,管理策略分为保守治疗(监测和影像学检查)或手术治疗(动脉瘤切除术、动脉供血支凝固或脊髓内出血清除术)。未观察到重大不良事件,所有患者在随访期间均表现出神经功能改善或仅存在轻度至中度残疾。
脊髓蛛网膜下腔出血可能是由于脊髓动脉瘤破裂所致,但在某些情况下,应考虑其他潜在病因作为出血来源。鉴于关于这种疾病的文献稀缺,明确正确诊断并实施针对患者的治疗方法至关重要。